The Statins Secret EVERY Senior Should Know
For decades, statins have been presented as a no-brainer.
High cholesterol?
Elevated heart risk score?
Over 40?
“Just take the statin.”
But what happens when people are actually told the real risks…and the dismal benefits?
A new study published in JAMA Internal Medicine asked exactly that question.
And the results shake up the entire cholesterol conversation.
Here’s the info you need before discussing statins with your doctor…
Researchers surveyed over 1,200 adults in the U.S. and Japan, ages 40–75, who had never taken a statin.
But this wasn’t a vague opinion poll.
Participants were carefully walked through:
- How much statins reduce risk
• The potential side effects
• The costs and inconvenience
• What their 10-year heart disease risk might look like
Only those who demonstrated they truly understood the information were allowed to continue.
Then came the key question:
How much risk reduction would make taking a daily statin “worth it” to you?
Here’s what they found.
Most people said they would only consider taking a statin if it reduced their cardiovascular risk by 50–75%.
That’s what felt meaningful to them, given all the risks and side effects that come with the drugs.
But here’s the problem: Statins don’t come close to reducing risk by 50–75%, and they never have.
In fact, even for people with known heart disease, you have to treat 39 patients for five years to prevent a single heart attack.
At a 10% 10-year heart disease risk (the level where guidelines recommend statins), only 23.6% of Americans surveyed said they’d be willing to take a statin.
Even if they had a 20% risk of heart disease over the next 10 years, only 34.2% were willing.
That means the majority of informed individuals would decline statins under current benefit levels.
Let that sink in.
The researchers called it a “discrepancy between patient and specialist perspectives.”
Translation:
Doctors and guideline committees may value modest statistical reductions differently than patients do.
But I think it means a whole lot more than that…
This research showed that most people wouldn’t take statins once they’re told how poorly they work. But we have more than 30 million Americans taking statins right now.
That tells me these people are not being informed about the limited benefits of statins… or the risks.
Bottom Line:
Patients need clear communication about absolute risk, not just relative percentages.
Because “25% risk reduction” sounds dramatic.
But if your risk drops from 10% to 7.5%, that’s a 2.5% absolute reduction.
For many people, that trade-off—weighed against daily medication, potential side effects, and cost—simply doesn’t feel worth it.
(If you want to explore alternatives, check out this seaweed secret that lowers cholesterol WITHOUT side effects.)
This is about informed consent. Shared decision-making.
Even for one of the most prescribed drugs in the world, expectations and reality may not align.
And as treatment thresholds keep dropping, one question becomes unavoidable:
Are patients being fully informed…or simply guided?
Because when people understand the numbers…most would say “no thanks” to statins.
To health on your terms,
Ray Thatcher
Research Director, Health Sciences Institute
Sources:
- Luo Y, Kawakami H, Funada S, et al. Measuring Public Preferences for Statin Therapy Using the Smallest Worthwhile Difference. JAMA Intern Med. Published online February 16, 2026. doi:10.1001/jamainternmed.2025.7958
- Newman, D. (2013, November 2). Statins for heart disease prevention (with known heart disease). TheNNT. https://thennt.com/nnt/statins-for-heart-disease-prevention-with-known-heart-disease/
- Phend, C. (2026, February 17). How much efficacy do statin users demand in primary prevention? — Study indicates daunting numbers. MedPage Today. https://www.medpagetoday.com/cardiology/dyslipidemia/119905
